'I took weight-loss jabs and had side effects that almost killed me'
'I took weight-loss jabs and had side effects that almost killed me'
Aimee, 34, was told she had a hole in her oesophagus and her liver was failing
Aimee was hospiatlised with liver failure (Kennedy News and Media)
A woman's bid to shed a few pounds using a weight-loss jab went horribly wrong when her hair fell out in clumps and she nearly lost her liver. Aimee Chapman began using the GLP-1-class weight loss injections in March last year after stumbling upon a post on social media. The 34-year-old hoped the fat jabs would help her lose weight and 'be taken more seriously' by doctors if she were slimmer. The family of drugs known as GLP-1 RAs, originally developed to treat diabetes, are now often being used for weight loss as they were found to suppress a patient's appetite. Aimee paid around £200 for a month's worth of jabs that she purchased from an online pharmacy - meaning it was completely legal and regulated. She lost four stone when she first began using the injectables, dropping from 14 stone to just 10 stone in four months. However, in June last year, Aimee began feeling more and more unwell - experiencing low energy levels, chest pains, diminished appetite and constant vomiting. After deciding to have her symptoms investigated in hospital, doctors discovered that Aimee had developed a hole in her oesophagus caused by vomiting 'more than 60 times'.
Aimee's hair started to fall out in clumps (Kennedy News and Media)
Aimee's liver then began showing signs of failure, with doctors even considering an organ transplant if her symptoms failed to improve. Luckily, Aimee was able to return home after 11 days in hospital - but soon began to notice her hair was coming out in clumps, a sign of vitamin deficiency that she believes is linked to the weight-loss jab. Aimee, who doesn't work due to her disability, is now calling on others who are considering using the injectables to do their research and consult a doctor. Aimee, who lives in Southampton, Hampshire, said: "I'd never even thought about it until I saw a post on social media saying you can just buy [weight-loss jabs]. "I noticed that as my weight changed, I was taken less seriously by doctors. My thinking was if I could weigh less, I would at least get taken a bit more seriously. It wasn't about getting thinner or looking better for me. That hadn't even crossed my mind.
The hair loss was linked to malnutrition (Kennedy News and Media)
"[After a few months of using the jabs] I started noticing I didn't have a lot of energy, I couldn't really do much. I was only eating a couple of times a week. I stopped being able to walk. I would take a couple of steps and have to stop. Then I couldn't stop being sick. "I was throwing up all the time and started throwing up blood. I was sick between 50 and 60 times. I collapsed a couple of times. My husband came home and found me passed out on the hallway one night. I was in a bit of denial about it being linked to the jab because I was fine up until now. I just thought I was poorly and it was some sort of virus." But when Aimee began experiencing chest pains, she went to Winchester Hospital's A&E where doctors discovered a hole in her oesophagus that was leaking air around her heart and lung. Aimee was then admitted to the intensive care unit when her blood pressure and potassium levels began to plummet.
Aimee lost so much hair she had to shave her head (Kennedy News and Media)
Aimee was later rushed to Southampton General Hospital's ICU when doctors noticed her liver function was deteriorating, prompting them to consider an organ transplant. Aimee said: "They were trying all sorts of things to get my liver levels back to normal. It was failing. "They had said it was down to the weight-loss jab but they didn't know why or how to fix it. There was so little out there medical-wise, doctors didn't know how to fix it. I was terrified. It all happened so quickly and I hadn't realised how serious it was until I was transferred and it sunk in that it was worse than I thought it was. "After coming out of ICU, the nurse told me this has happened because of these jabs and I can never take one ever again even if I had type-2 diabetes. I don't think they know whether this was a general side-effect or whether this was a rare case. I was really surprised about how much of my body it affected.
Aimee with her husband Christopher (Kennedy News and Media)
Article continues below
"I was told the hole in the oesophagus can kill people and I may have needed a new liver. They said I could've died." Luckily, Aimee's health began to improve and she was discharged from hospital. But, the decline in her health and a consequential vitamin B-12 deficiency led to Aimee's hair falling out in September last year. Aimee said: "It kept happening and the handfuls kept getting bigger. I would be so sad. My hair was just above my bum when I went into hospital. My husband just said why don't you just cut it off? My hair was such a massive part of my identity and to cut it off just felt really traumatic. But I said to myself it was just hair, it'll grow back. "This feels like another result of the injections. I'm not going to tell people what they can and can't take but I do believe more research needs to be done into these jabs. I regret ever taking them. I'd say to other people thinking about trying them, don't do it online, go through your doctor who can give you blood tests and check how you're doing."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
9 hours ago
- Scottish Sun
New ‘Ozempic pill' is better than ‘skinny jabs' and helps you lose weight even faster, study suggests
The new weight loss pill has seen promising results and offers hope to millions WEIGH TO GO New 'Ozempic pill' is better than 'skinny jabs' and helps you lose weight even faster, study suggests Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A NEW 'Ozempic pill' leads to faster weight loss than the popular 'skinny jabs', studies have suggested. The new weight loss medication, which can also be offered by injection, can help patients lose a significant amount of weight. Sign up for Scottish Sun newsletter Sign up 1 The new weight loss pill has seen promising results in early trials Credit: Getty An early study found that patients who received amycretin as a weekly jab lost 24% of their body weight after 36 weeks of treatment. But initial trials assessing a tablet form of the jab saw promising results with patients losing an average 13% of bodyweight in just three months. This suggests the drug leads to greater weight loss than Wegovy, the 'sister jab' of Ozempic. Such treatments have been called transformative by NHS leaders. It's estimated that around 1.5 million Brits currently receive weight loss jabs through specialist weight loss services or private prescriptions. But weight pills offer a new hope to millions looking to lose weight as the injections put additional pressure on an overstretched NHS. However, further clinical trials are needed before the treatment can be made available in the UK. This could take several years and there's no guarantee that regulators will approve the use of the drug. Amycretin, made by Novo Nordisk, contains semaglutide, the same active ingredient as Ozempic and Wegovy and helps control blood sugar and appetite. It targets specific receptors in the body - the GLP-1 and amylin receptors - helping you feel full and stops overeating. An early trial published in The Lancet found that 125 adults taking weekly injections containing higher doses of the drug lost nearly a quarter of their body weight after 36 weeks. It also showed signs of improving blood sugar levels. However, there were some mild to moderate side effects including nausea and vomiting but these were resolved by the end of the treatment. Experts said that the medicine appeared "safe and tolerable" but further studies were needed to fully assess the drug. But a second trial, also published in The Lancet, assessed the drug in tablet form in 144 people. Those taking the highest dose of 100mg lost 13% of their body weight over four months. Weight Loss Jabs - Pros vs Cons The authors wrote: "Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people who were overweight or obese. "Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen." As with the first trial, there were also some mild to moderate side effects including loss of appetite and similar gastrointestinal issues. It comes as a separate study examined the effects of the weight-loss jab, Wegovy, at higher doses. The researchers found that giving patients 7.2mg of Wegovy once a week led to an average weight loss of 21%, with a third of participants losing 25% of their body weight over 72 weeks. The studies were also presented to the American Diabetes Association's Scientific Sessions in Chicago.
Wales Online
16 hours ago
- Wales Online
The new weight loss pill showing significant results within 12 weeks
The new weight loss pill showing significant results within 12 weeks The weight loss pill has showed promise in new trials with some reporting up to 24% weight loss The experimental drug tests have shown up to 24% weight loss (Image: PA ) An early study has found that a new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight. It has found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Stay informed on the latest health news by signing up to our newsletter here Article continues below Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body - GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. "These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity," the authors wrote. "Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment." The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: "Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. "Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen." The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Article continues below Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
South Wales Guardian
21 hours ago
- South Wales Guardian
Weight loss pill shows promise in new trial
An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
